4-Butylresorcinol (CAS No 18979-61-8) is a compound prominently used in the biomedical research field particularly in dermatological studies It originates from the class of resorcinols and acts as an inhibitor of tyrosinase reducing melanin synthesis by targeting pathways involved in pigmentation This mechanism makes it a subject of interest for investigations into skin lightening and hyperpigmentation treatments In vitro activity is observed in the nanomolar to low micromolar range indicating high potency Typical applications include studies on various cell models like melanocytes and keratinocytes as well as in vivo animal studies to explore its therapeutic potential in skin disorders It is also utilized in drug screening processes to assess its efficacy and safety profile Experimental concentrations typically depend on the specific research design adjusted according to the study s requirements